Cincinnati Eye Institute

Blue Ash, Ohio 45242-5537

2 studies enrolling now · 5 studies all time

What they study most

Cataract, Corneal Astigmatism, Diabetic Macular Edema, Geographic Atrophy, Neovascular Age-related Macular Degeneration

Studies at this site

• A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 — Recruiting now
• A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) — Recruiting now
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema — Completed
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
• Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular Lens — Completed